Use of Chromatin Immunoprecipitation To Clone Novel E2F Target Promoters

REFERENCES

• Aita, V. M., X. H. Liang, V. V. Murty, D. L. Pincus, W. Yu, E. Cayanis, S. Kalachikov, T. C. Gilliam, and B. Levine. 1999. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 59:59–65.
   PubMed Web of Science ®Google Scholar
• Albert, T., J. Wells, J.-O. Funk, A. Pullner, E.-E. Raschke, G. Stelzer, M. Meisterernst, P. J. Farnham, and D. Eick. 2001. The chromatin structure of the dual c-Myc promoter P1/P2 is regulated by separate elements. J. Biol. Chem. 276:20482–20490.
   PubMedGoogle Scholar
• Boyd, K. E., J. Wells, J. Gutman, S. M. Bartley, and P. J. Farnham. 1998. c-Myc target gene specificity is determined by a post-DNA-binding mechanism. Proc. Natl. Acad. Sci. USA 95:13887–13892.
   PubMed Web of Science ®Google Scholar
• Bussemaker, H. J., H. Li, and E. D. Siggia. 2001. Regulatory element detection using correlation with expression. Nat. Genet. 27:167–174.
   PubMed Web of Science ®Google Scholar
• Cohen-Kaminsky, S., L. Maouche-Chretien, L. Vitelli, M.-A. Vinit, I. Blanchard, M. Yamamoto, C. Peschle, and P.-H. Romeo. 1998. Chromatin immunoselection defines a TAL-1 target. EMBO J. 17:5151–5160.
   PubMedGoogle Scholar
• de Belle, I., D. Mercola, and E. D. Adamson. 2000. Method for cloning in vivo targets of the Egr-1 transcription factor. BioTechniques 29:162–169.
   PubMed Web of Science ®Google Scholar
• Dyson, N.. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245–2262.
   PubMed Web of Science ®Google Scholar
• Eberhardy, S. E., C. A. D'Cunha, and P. J. Farnham. 2000. Direct examination of histone acetylation on Myc target genes using chromatin immunoprecipitation. J. Biol. Chem. 275:33798–33805.
   PubMed Web of Science ®Google Scholar
• Farnham, P. J., J. E. Slansky, and R. Kollmar. 1993. The role of E2F in the mammalian cell cycle. Biochim. Biophys. Acta 1155:125–131.
   PubMed Web of Science ®Google Scholar
• Grandori, C., J. Mac, F. Siebelt, D. E. Ayer, and R. N. Eisenman. 1996. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J. 15:4344–4357.
   PubMed Web of Science ®Google Scholar
• Graveel, C. R., T. Jatkoe, S. J. Madore, A. L. Holt, and P. J. Farnham. 2001. Expression profiling and identification of novel genes in hapatocellular carcinomas. Oncogene 20:2704–2712.
   PubMed Web of Science ®Google Scholar
• Halle, J. P., P. Haus-Seuffert, C. Woltering, G. Stelzer, and M. Meisterernst. 1997. A conserved tissue-specific structure at a human T-cell receptor beta-chain core promoter. Mol. Cell. Biol. 17:4220–4229.
   PubMed Web of Science ®Google Scholar
• Hines, W. A., J. Thorburn, and A. Thorburn. 1999. A low-affinity serum response element allows other transcription factors to activate inducible gene expression in cardiac myocytes. Mol. Cell. Biol. 19:1841–1852.
   PubMedGoogle Scholar
• Hsiao, K.-M., S. L. McMahon, and P. J. Farnham. 1994. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev. 8:1526–1537.
   PubMed Web of Science ®Google Scholar
• Ioshikhes, I. P., and M. Q. Zhang. 2000. Large-scale human promoter mapping using CpG islands. Nat. Genet. 26:61–63.
   PubMed Web of Science ®Google Scholar
• Ishida, S., E. Huang, H. Zuzan, R. Spang, G. Leone, M. West, and J. R. Nevins. 2001. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol. Cell. Biol. 21:4684–4699.
   PubMed Web of Science ®Google Scholar
• Johansen, L. M., A. Iwama, T. A. Lodie, K. Sasaki, D. W. Felsher, T. R. Golub, and D. G. Tenen. 2001. c-Myc is a critical target for C/EBPα in granulopoiesis. Mol. Cell. Biol. 21:3789–3806.
   PubMed Web of Science ®Google Scholar
• Johnson, D. G., K. Ohtani, and J. R. Nevins. 1994. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev. 8:1514–1525.
   PubMed Web of Science ®Google Scholar
• Johnson, D. G., J. K. Schwarz, W. D. Cress, and J. R. Nevins. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365:349–352.
   PubMed Web of Science ®Google Scholar
• Karlseder, J., H. Rotheneder, and E. Wintersberger. 1996. Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol. Cell. Biol. 16:1659–1667.
   PubMed Web of Science ®Google Scholar
• Kel, A. E., O. V. Kel-Margoulis, P. J. Farnham, S. M. Bartley, E. Wingender, and M. Q. Zhang. 2001. Computer-assisted identification of cell cycle-related genes—new targets for E2F transcription factors. J. Mol. Biol. 309:99–120.
   PubMedGoogle Scholar
• Kim, J. H., P. Hui, D. Yue, J. Aycock, C. Leclerc, A. R. Bjoring, and A. S. Perkins. 1998. Identification of candidate target genes for EVI-1, a zinc finger oncoprotein, using a novel selection strategy. Ocogene 17:1527–1538.
   PubMedGoogle Scholar
• Kowalik, T. F., J. DeGregori, J. K. Schwarz, and J. R. Nevins. 1995. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol. 69:2491–2500.
   PubMedGoogle Scholar
• Lee, T. A., and P. J. Farnham. 2000. Exogenous E2F1 is growth inhibitory before, during, and after neoplastic transformation. Oncogene 19:2257–2268.
   PubMedGoogle Scholar
• Li, Y., J. E. Slansky, D. J. Myers, N. R. Drinkwater, W. G. Kaelin, and P. J. Farnham. 1994. Cloning, chromosomal location, and characterization of mouse E2F1. Mol. Cell. Biol. 14:1861–1869.
   PubMedGoogle Scholar
• Liang, X. H., S. Jackson, M. Seaman, K. Brown, B. Kempkes, H. Hibshoosh, and B. Levine. 1999. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402:672–676.
   PubMed Web of Science ®Google Scholar
• Lin, S. Y., A. R. Black, D. Kostic, S. Pajovic, C. N. Hoover, and J. C. Azizkhan. 1996. Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction. Mol. Cell. Biol. 16:1668–1675.
   PubMed Web of Science ®Google Scholar
• Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
   Google Scholar
• McNally, J. G., W. G. Muller, D. Walker, R. Wolford, and G. L. Hager. 2000. The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science 287:1262–1265.
   PubMed Web of Science ®Google Scholar
• Moberg, K. H., T. J. Logan, W. A. Tyndall, and D. J. Hall. 1992. Three distinct elements within the murine c-myc promoter are required for transcription. Oncogene 7:411–421.
   PubMedGoogle Scholar
• Muller, H., A. P. Bracken, R. Vernell, M. C. Moroni, F. Christians, E. Grassilli, E. Prosperini, E. Vigo, J. D. Oliner, and K. Helin. 2001. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 15:267–285.
   PubMed Web of Science ®Google Scholar
• Neuman, E., E. K. Flemington, W. R. Sellers, and W. G. Kaelin Jr.. 1994. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol. Cell. Biol. 14:6607–6615 (Erratum, 15:4660, 1995.)
   PubMed Web of Science ®Google Scholar
• Orlando, V., H. Strutt, and R. Paro. 1997. Analysis of chromatin structure by in vivo formaldehyde cross-linking. Methods 11:205–214.
   PubMed Web of Science ®Google Scholar
• Oswald, F., H. Lovec, T. Möröy, and M. Lipp. 1994. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions. Oncogene 9:2029–2036.
   PubMedGoogle Scholar
• Pearson, A., and J. Greenblatt. 1997. Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH. Oncogene 15:2643–2658.
   PubMedGoogle Scholar
• Phelps, D. E., and G. R. Dressler. 1996. Identification of novel Pax-2 binding sites by chromatin precipitation. J. Biol. Chem. 271:7978–7985.
   PubMedGoogle Scholar
• Qin, X.-Q., D. M. Livingston, W. G. Kaelin, and P. D. Adams. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91:10918–10922.
   PubMed Web of Science ®Google Scholar
• Robinson, L., A. Panayiotakis, T. S. Papas, I. Kola, and A. Seth. 1997. ETS target genes: identification of egr1 as a target by RNA differential display and whole genome PCR techniques. Proc. Natl. Acad. Sci. USA 94:7170–7175.
   PubMedGoogle Scholar
• Scherf, M., A. Klingenhoff, and T. Werner. 2000. Highly specific localization of promoter regions in large genomic sequences by PromoteInspector: a novel context analysis approach. J. Mol. Biol. 297:599–606.
   PubMedGoogle Scholar
• Shan, B., and W.-H. Lee. 1994. Deregulated expression of E2F1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14:8166–8173.
   PubMedGoogle Scholar
• Singh, P., S. H. Wong, and W. Hong. 1994. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J. 13:3329–3338.
   PubMed Web of Science ®Google Scholar
• Slansky, J. E., and P. J. Farnham. 1993. The role of the transcription factor E2F in the growth regulation of DHFR. Plenum Press, New York, N.Y
   Google Scholar
• Slansky, J. E., Y. Li, W. G. Kaelin, and P. J. Farnham. 1993. A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol. Cell. Biol. 13:1610–1618 (Erratum, 13:7201.)
   PubMed Web of Science ®Google Scholar
• Slomiany, B. A., K. L. D'Arigo, M. M. Kelly, and D. T. Kurtz. 2000. C/EBPα inhibits cell growth via direct repression of E2F-DP-mediated transcription. Mol. Cell. Biol. 20:5986–5987.
   PubMed Web of Science ®Google Scholar
• Strutt, D. I., and R. A. H. White. 1994. Characterisation of T48: a target of homeotic gene regulation in Drosophila embryogenesis. Mech. Dev. 46:27–39.
   PubMedGoogle Scholar
• Tomotsune, D., H. Shoji, Y. Wakamatsu, H. Kondoh, and N. Takahashi. 1993. A mouse homologue of the Drosophila tumor suppressor gene 1(2)gl controlled by HoxC8 in vivo. Nature 365:69–72.
   PubMed Web of Science ®Google Scholar
• van Ginkel, P. R., K.-M. Hsiao, H. Schjerven, and P. J. Farnham. 1997. E2F-mediated growth regulation requires transcription factor cooperation. J. Biol. Chem. 272:18367–18374.
   PubMedGoogle Scholar
• Watanabe, G., C. Albanese, R. J. Lee, A. Reutens, G. Vairo, B. Henglein, and R. G. Pestell. 1998. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol. Cell. Biol. 18:3212–3222.
   PubMed Web of Science ®Google Scholar
• Wells, J., K. E. Boyd, S. M. Bartley, and P. J. Farnham. 2000. Binding specificity of E2F and pocket protein family members in living cells. Mol. Cell. Biol. 20:5797–5807.
   PubMed Web of Science ®Google Scholar
• Wong, K. K., X. Zou, K. T. Merrell, A. J. Patel, K. B. Marcu, S. Chellappan, and K. Calame. 1995. v-Abl activates c-myc transcription through the E2F site. Mol. Cell. Biol. 15:6535–6544.
   PubMedGoogle Scholar
• Wu, X., and A. J. Levine. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91:1–5.
   PubMed Web of Science ®Google Scholar